Paola M. Arbour
Paola M. Arbour's purchase track record
Paola M. Arbour has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/11/2026 | TCBI | $92K | +10.4% | +7.5% | +12.7% |
| 11/19/2021 | TCBI | $15K | +13.4% | -12.0% | -17.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
TCBI Expected to Beat Q3 Earnings Estimates. Analysts expect Texas Capital Bancshares to report earnings above estimates for the third quarter. This positive outlook comes as the stock trades near a key support level, with an average analyst target of $105.08. The company's trailing P/E ratio stands at 10.6, reflecting current market valuation relative to its earnings.
Transaction History
| THC | ▼ Sell | Open Market | 10,878 | $2.7M | 7/27/2026 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,670 | $0 | 4/22/2026 | View on chart |
| THC | ▼ Sell | Open Market | 6,500 | $1.5M | 3/11/2026 | View on chart |
| TCBI | ▲ Buy | Open Market | 1,000 | $92K | 3/11/2026 | View on chart |
| THC | ▼ Sell | Tax Withholding | 499 | $119K | 2/27/2026 | View on chart |
| THC | ▼ Sell | Tax Withholding | 6,810 | $1.6M | 2/27/2026 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,799 | — | 2/27/2026 | View on chart |
| THC | ▲ Buy | Option Exercise | 1,868 | — | 2/27/2026 | View on chart |
| THC | ▼ Sell | Tax Withholding | 1,838 | $440K | 2/27/2026 | View on chart |
| THC | ▲ Buy | Option Exercise | 1,267 | — | 2/24/2026 | View on chart |
| THC | ▲ Buy | Grant | 18,894 | $0 | 2/13/2026 | View on chart |
| THC | ▼ Sell | Open Market | 7,738 | $1.3M | 6/5/2025 | View on chart |
| THC | ▼ Sell | Open Market | 6,461 | $1.0M | 5/15/2025 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,330 | $0 | 4/23/2025 | View on chart |
| THC | ▼ Sell | Tax Withholding | 1,838 | $233K | 3/3/2025 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,799 | — | 2/28/2025 | View on chart |
| THC | ▲ Buy | Option Exercise | 1,868 | — | 2/28/2025 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,107 | — | 2/21/2025 | View on chart |
| THC | ▼ Sell | Tax Withholding | 830 | $108K | 2/21/2025 | View on chart |
| THC | ▼ Sell | Tax Withholding | 3,845 | $498K | 2/21/2025 | View on chart |
| THC | ▲ Buy | Grant | 12,622 | $0 | 2/11/2025 | View on chart |
| THC | ▼ Sell | Open Market | 8,377 | $1.3M | 8/16/2024 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,631 | $0 | 4/18/2024 | View on chart |
| THC | ▼ Sell | Open Market | 18,168 | $1.8M | 3/6/2024 | View on chart |
| THC | ▼ Sell | Tax Withholding | 1,102 | $104K | 3/1/2024 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,799 | — | 3/1/2024 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,839 | — | 2/24/2024 | View on chart |
| THC | ▼ Sell | Tax Withholding | 1,118 | $104K | 2/24/2024 | View on chart |
| THC | ▼ Sell | Tax Withholding | 6,736 | $625K | 2/24/2024 | View on chart |
| THC | ▼ Sell | Tax Withholding | 830 | $77K | 2/23/2024 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,107 | — | 2/23/2024 | View on chart |
| THC | ▲ Buy | Grant | 17,006 | $0 | 2/15/2024 | View on chart |
| THC | ▲ Buy | Option Exercise | 17,205 | $610K | 6/2/2023 | View on chart |
| THC | ▼ Sell | Open Market | 17,205 | $1.3M | 6/2/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 21,351 | $603K | 6/2/2023 | View on chart |
| THC | ▼ Sell | Open Market | 21,351 | $1.6M | 6/2/2023 | View on chart |
| TCBI | ▲ Buy | Option Exercise | 1,377 | $0 | 4/19/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,106 | — | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 829 | $50K | 3/6/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,838 | — | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 1,117 | $66K | 3/6/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 5,396 | — | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 2,124 | $126K | 3/6/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 25,854 | — | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 7,686 | $456K | 3/6/2023 | View on chart |
| TCBI | ▲ Buy | Grant | 1,377 | $0 | 4/19/2022 | View on chart |
| THC | ▲ Buy | Option Exercise | 5,396 | — | 2/25/2022 | View on chart |
| THC | ▼ Sell | Tax Withholding | 1,314 | $113K | 2/25/2022 | View on chart |
| THC | ▲ Buy | Option Exercise | 3,146 | — | 2/25/2022 | View on chart |
| THC | ▼ Sell | Tax Withholding | 767 | $66K | 2/25/2022 | View on chart |
| THC | ▲ Buy | Option Exercise | 2,838 | — | 2/24/2022 | View on chart |
| THC | ▼ Sell | Tax Withholding | 731 | $59K | 2/24/2022 | View on chart |
| TCBI | ▲ Buy | Open Market | 251 | $15K | 11/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Tenet Healthcare Raises 2026 Outlook, Analysts Lift Targets
Tenet Healthcare recently raised its 2026 financial outlook, prompting analysts like Guggenheim to increase price targets to $307. This positive guidance has driven the stock higher, with the average analyst target now sitting at $285.32. While the company is trading near its 52-week high, questions remain about whether this recent strength is fully reflected in the current valuation.
Tenet Healthcare Raises 2026 Outlook, Analysts Lift Targets. Tenet Healthcare recently raised its 2026 financial outlook, prompting analysts like Guggenheim to increase price targets to $307. This positive guidance has driven the stock higher, with the average analyst target now sitting at $285.32. While the company is trading near its 52-week high, questions remain about whether this recent strength is fully reflected in the current valuation.